Choosing a Physician-Led Peptide Therapy Doctor in NYC

One of the most important questions a patient can ask is: Who is medically responsible for my evaluation and treatment?

Peptide therapy should not begin with selecting a product from an online catalog. It should begin with a medical evaluation. An appropriate evaluation may consider:

• Current health concerns and goals
• Medical history
• Prescription medications
• Supplements
• Allergies
• Previous treatments
• Relevant laboratory findings
• Risk factors
• Contraindications
• Whether treatment is medically appropriate

At PeptideDoc, Dr. Maslavi oversees medical evaluations, individualized treatment decisions, monitoring, and follow-up care for eligible patients.

A consultation should determine whether a treatment is appropriate—not simply confirm a treatment a patient has already decided to purchase.

FDA-approved medications have undergone review by the U.S. Food and Drug Administration for safety, effectiveness, and quality for their approved uses.

Compounded medications are different. Compounded medications are not FDA-approved. The FDA explains this in its compounding questions and answers (opens in a new tab) and its human drug compounding resources (opens in a new tab).

Compounded medications may be considered for certain patients when clinically appropriate. They should not be represented as FDA-approved generic equivalents simply because they contain a similar active ingredient.

Questions patients should ask

• Is this medication FDA-approved?
• What condition is it approved to treat?
• Is the proposed use on-label or off-label?
• Is the medication compounded?
• Why is a compounded medication being considered?
• Where is the medication prepared?
• What alternatives are available?
• What are the known risks and uncertainties?

Not every patient requires the same laboratory testing. Laboratory testing may sometimes help a physician understand metabolic health, risk factors, treatment suitability, and response to therapy.

When clinically appropriate, testing may include:

• Blood glucose and metabolic health
• Kidney function
• Liver function
• Lipid levels
• Hormonal status where clinically relevant
• Other measurements based on medical history and proposed treatment

Why is this test being ordered, and how will the result affect my treatment decision?

Laboratory testing should be clinically driven. It should not be used merely to justify a predetermined treatment package.

Patients with similar goals can have very different medical histories, medication profiles, risk factors, and contraindications. PeptideDoc does not use a one-size-fits-all peptide protocol.

Patients should be cautious of providers that appear to offer:

• The same peptide combination to nearly everyone
• Treatment without meaningful medical evaluation
• Guaranteed results
• Extremely broad claims covering unrelated medical conditions
• Prescription medication without clearly identified physician oversight
• Minimal discussion of risks, contraindications, or alternatives

The term “peptide therapy” covers very different substances and treatment categories.

• Some peptide-based medications have undergone FDA review for specific indications.
• Some medications may be used off-label under physician judgment.
• Some compounded peptide substances have more limited evidence.
• Regulatory status and evidence should be discussed for the specific medication being considered.

The FDA has published information on certain bulk drug substances used in compounding that may present significant safety risks (opens in a new tab).

What specific medication is being considered, what evidence supports its use for me, what is its regulatory status, and what are the known and unknown risks?

Medical weight management is another area where regulatory distinctions matter.

• FDA-approved GLP-1 medications exist for specific indications.
• Compounded versions are not FDA-approved.
• Patients should understand sourcing, formulation, dosing, and administration.
• FDA-approved options should be considered when medically appropriate.

Read the FDA’s concerns with unapproved GLP-1 drugs used for weight loss (opens in a new tab) and its information on medications containing semaglutide (opens in a new tab). PeptideDoc also explains semaglutide and tirzepatide care in more detail.

At PeptideDoc, medical weight-management decisions are made following physician evaluation rather than through automatic online medication fulfillment.

Physician oversight should continue after treatment starts. Depending on the therapy and patient, follow-up may consider:

• Symptoms
• Side effects
• Treatment response
• Relevant laboratory findings
• Changes in health status
• New medications
• Whether treatment should continue, change, or stop

What happens after I start treatment, and who do I contact if I experience a problem?

Use these questions when comparing providers. More general questions are answered on our peptide therapy FAQs page.

Peptide therapy is not appropriate for everyone. A physician may determine that treatment should not begin because of:

• Medical history
• Current medications
• Contraindications
• Risk factors
• Laboratory findings
• Insufficient expected benefit
• A safer or better-supported alternative treatment

The appropriate outcome of a medical consultation can be: “This treatment is not recommended for you.”

At PeptideDoc, consultation does not guarantee treatment eligibility or a prescription. Recommendations are made following medical evaluation.

Patients searching for a peptide therapy doctor in NYC should look beyond convenience and marketing claims. Look for a practice where you can clearly identify:

• The physician
• The medical evaluation process
• The medication being considered
• Its regulatory status
• The clinical rationale
• Risks and alternatives
• The monitoring and follow-up plan

PeptideDoc is a physician-led medical wellness practice located in Bayside, Queens, serving patients from New York City and the Tri-State area.

Care is overseen by:

Saul F. Maslavi, MD
Founder & Owner, PeptideDoc
Board-Certified Family Medicine Physician
NPI 1134137383

PeptideDoc emphasizes physician evaluation, individualized treatment decisions, appropriate monitoring, and transparent communication regarding FDA-approved and compounded medications. Learn more about physician-led peptide therapy at PeptideDoc or visit the Bayside, Queens medical office.